Early evaluation of response to sorafenib for hepatocellular carcinoma by duplex Doppler ultrasonography.

Aim: Early evaluation of the response to sorafenib for patients with hepatocellular carcinoma (HCC) remains unclear. This prospective study investigated the early evaluation of the efficacy of sorafenib in patients with advanced HCC using duplex Doppler ultrasonography (DDU).

Methods: Thirty-seven Child-Pugh class-A advanced HCC patients treated with sorafenib 400 mg b.

Total and viable residual splenic volume measurement after partial splenic embolization by three-dimensional ultrasound.

Purpose: We prospectively evaluated the validity of total and viable residual splenic volume after partial splenic embolization (PSE) with three-dimensional (3D) ultrasound (US) measurement.

Methods: Twenty patients with splenomegaly were included. All splenic volumes were measured with transabdominal US using virtual organ computer-aided analysis (VOCAL).